Adagene Insider Trades
NASDAQ: ADAGHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 5 · $162.24K
- Sales
- 0 · $0
- Shares bought / sold
- 47.53K / 0
- Net activity
- Net buying $162,244
Adagene insider activity
Over the last 12 months, Adagene insiders reported 5 transactions on SEC Form 4: 5 open-market purchases and 0 sales. Insiders bought $162,244 and sold $0 worth of stock, for net insider buying of $162,244. The most recent filing shows Tam Man Kin (Chief Financial Officer) buying 2,000 shares at $3.00 on Sep 23, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ADAG's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ADAG insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 23, 2026 | Tam Man KinChief Financial Officer | Buy | 2,000 | $6.00K | Form 4 |
| Sep 16, 2026 | Luo PeterChief Executive Officer | Buy | 20,290 | $63.98K | Form 4 |
| Aug 14, 2026 | DO CUONG VDirector | Buy | 2,000 | $7.50K | Form 4 |
| Aug 5, 2026 | Luo PeterChief Executive Officer | Buy | 279 | $1.02K | Form 4 |
| Aug 4, 2026 | Luo PeterChief Executive Officer | Buy | 22,966 | $83.75K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4